Although the prognostic significance of CCL11 in prostate cancer remains undefined, these findings suggest its potential utility as a diagnostic biomarker for distinguishing between normal and pathological prostate conditions [69]. The gene discussed is CCL11; the disease is Familial prostate cancer.